Skip to main content

Year: 2024

Crazy Woman Creek Bancorp Reports Earnings for Fiscal Year 2024; Declares Annual Cash Dividend of $0.32 Per Share

BUFFALO, Wyo., Dec. 23, 2024 (GLOBE NEWSWIRE) — We continue to build our franchise as Crazy Woman Creek Bancorp (OTCPink: CRZY) and Buffalo Federal Bank, known as The Banks of Buffalo, Sheridan, Gillette and BFSB Mortgage of Evanston. Headquartered in Buffalo, Wyoming, our bank remains a vital business and community partner since founding in 1936. We take great pride in meeting our customers’ banking needs with a passion for local decision-making and personal involvement in our communities. Our vision remains to be the premier community bank serving the needs of individuals, families and businesses throughout North-Central Wyoming. Given our commitment to shareholders, we have declared an annual cash dividend of $0.32 per share to be paid in January 2025. Crazy Woman Creek Bancorp is proud to have posted the second-best performance...

Continue reading

GRI Bio Announces European Patent Office Issued a Decision to Grant Notice for Patent Covering GRI-0803 and Its Library of 500+ Proprietary Compounds

– Company committed to building a robust global patent estate across its innovative pipeline of NKT cell modulators LA JOLLA, CA, Dec. 23, 2024 (GLOBE NEWSWIRE) — GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, today announced that European Patent Office (EPO) has issued a decision to grant notice for patent application number 19,166,502 titled, “Oxygenated Amino- or Ammonium-Containing Sulfonic Acid, Phosphonic Acid and Carboxylic Acid Derivatives and Their Medical Use.” Based on the intention to grant notice, the Company expects the EPO to issue a patent January 16, 2025. “We have continued to make encouraging progress in our initiative to bolster our...

Continue reading

Kura Sushi USA to Announce Fiscal First Quarter 2025 Financial Results on January 7, 2025

IRVINE, Calif., Dec. 23, 2024 (GLOBE NEWSWIRE) — Kura Sushi USA, Inc. (“Kura Sushi” or the “Company”), (NASDAQ: KRUS), a technology-enabled Japanese restaurant concept, today announced that it will host a conference call to discuss fiscal first quarter 2025 financial results on Tuesday, January 7, 2025 at 5:00 p.m. ET. A press release with fiscal first quarter 2025 financial results will be issued that same day after the market closes. Hosting the conference call and webcast will be Hajime “Jimmy” Uba, President and Chief Executive Officer, Jeff Uttz, Chief Financial Officer, and Benjamin Porten, SVP Investor Relations & System Development. Interested parties may listen to the conference call via telephone by dialing 201-689-8471. A telephone replay will be available shortly after the call has concluded and can be accessed...

Continue reading

Borqs Technologies Reports Half-Year 2024 Financial Results; Successfully Increases Efficiency

SANTA CLARA, Calif., Dec. 23, 2024 (GLOBE NEWSWIRE) — Borqs Technologies, Inc. (U.S. OTC: BRQSF, “Borqs” or the “Company”), a global provider of embedded software and products for the Internet of Things (IoT), today announced its financial results for the first half of 2024. Interim financial statements were filed today with the SEC. First-Half 2024 Financial Highlights  For the six months ended June 30,  2024 2023 vs. H1 2023              Revenues ($K) 16,773 14,992 + 11.9%Gross Margin 20.2% 19.4% Up 0.8%Operating expenses ($K) 7,082 11,996 – 41.0%Net income (loss) from operations 15,023 -28,801 n/a       For the six months ended June 30, 2024, Borqs reported total net revenues of US$16.77 million, reflecting an increase from US$14.99 million in the same period of 2023, an increase of 11.9%,...

Continue reading

PIMCO Canada Announces Closing of the Mergers of Certain Closed-end Funds

TORONTO, Dec. 23, 2024 (GLOBE NEWSWIRE) — PIMCO Canada Corp. (“PIMCO Canada”) is pleased to announce that the previously announced reorganization of PIMCO Tactical Income Fund (TSX: PTI.UN), PIMCO Tactical Income Opportunities Fund (TSX: PTO.UN) and PIMCO Multi-Sector Income Fund (TSX: PIX.UN) (collectively, the “Funds”) with PIMCO Monthly Enhanced Income Fund (“PMEI”) (the “Mergers”) was completed following the close of business on December 20, 2024.  Pursuant to the Mergers, PMEI acquired all of the outstanding units of each Fund in exchange for Class A units (the “PMEI Units”) of PMEI.  Each unitholder of each Fund received, as of the close of business on December 20, 2024, such number of PMEI Units as is equal to the number of units of the applicable Fund held multiplied by the exchange ratio noted in the table below (the “Exchange...

Continue reading

First Busey Corporation and CrossFirst Bankshares, Inc. Announce Shareholder Approvals of Merger

CHAMPAIGN, Ill. and LEAWOOD, Kan., Dec. 23, 2024 (GLOBE NEWSWIRE) — First Busey Corporation (“First Busey”) (Nasdaq: BUSE), the holding company of Busey Bank, and CrossFirst Bankshares, Inc. (“CrossFirst”) (Nasdaq: CFB), the holding company of CrossFirst Bank, today jointly announced that First Busey shareholders and CrossFirst shareholders have each voted to adopt and approve, as applicable, all proposals relating to the previously announced merger in which First Busey will acquire CrossFirst. The special shareholder meetings were held on Friday, December 20, 2024. “Our shareholders’ overwhelming approval of this business combination is an important milestone in the process of closing this transaction,” said First Busey Chairman and CEO Van Dukeman. “This approval reflects our shareholders’ confidence in this compelling merger...

Continue reading

First Busey Corporation and CrossFirst Bankshares, Inc. Announce Shareholder Approvals of Merger

CHAMPAIGN, Ill. and LEAWOOD, Kan., Dec. 23, 2024 (GLOBE NEWSWIRE) — First Busey Corporation (“First Busey”) (Nasdaq: BUSE), the holding company of Busey Bank, and CrossFirst Bankshares, Inc. (“CrossFirst”) (Nasdaq: CFB), the holding company of CrossFirst Bank, today jointly announced that First Busey shareholders and CrossFirst shareholders have each voted to adopt and approve, as applicable, all proposals relating to the previously announced merger in which First Busey will acquire CrossFirst. The special shareholder meetings were held on Friday, December 20, 2024. “Our shareholders’ overwhelming approval of this business combination is an important milestone in the process of closing this transaction,” said First Busey Chairman and CEO Van Dukeman. “This approval reflects our shareholders’ confidence in this compelling merger...

Continue reading

TX Rail Products, Inc. Reports Revenue Growth of 16% for Fiscal 2024

Gross Profit Margin Increases; Net Income Doubles ASHLAND, Ky., Dec. 23, 2024 (GLOBE NEWSWIRE) — TX Rail Products, Inc. (OTC Markets PINK: TXRP), a supplier of rail and rail products to the U.S. coal mining industry, short line railroads and tunneling contractors, today announced financial results for its fiscal year 2024. Mr. Shrewsbury, CEO and Chairman of TX Rail Products, Inc., commented, “For fiscal year 2024, we delivered double-digit revenue growth of 16% and with disciplined cost management, we more than doubled our net income. Importantly, we are generating positive cash from operations, thereby strengthening our balance sheet, self-funding our business and enabling the repurchase of our common stock.” Shrewsbury continued, “Demand remains robust for our rail products, as our reputation for excellent customer service combined...

Continue reading

Ikena Oncology and Inmagene Biopharmaceuticals Announce Agreement for Merger and Private Placement

Inmagene Biopharmaceuticals is a clinical stage company focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody with an extended half-life and a silenced ADCC function The transaction is expected to result in approximately $175 million to support further development of IMG-007, including $75 million from an oversubscribed Private Placement that will close immediately following the merger The Financing includes both new investors such as Deep Track Capital, Foresite Capital, RTW Investments, and existing Ikena investors such as BVF Partners L.P., Blue Owl Healthcare Opportunities, Omega Funds, and OrbiMed The transaction is expected to close in mid-2025 BOSTON, Mass. and SAN DIEGO, Calif., Dec. 23, 2024 (GLOBE NEWSWIRE) — Ikena Oncology, Inc. (Nasdaq: IKNA, “Ikena,”) and Inmagene Biopharmaceuticals (“Inmagene”)...

Continue reading

APA Corporation Announces Results of Private Exchange Offers, Tender Offers, and Consent Solicitations at Extended Early Consent Date and Upsizing of Tender Offers

HOUSTON, Dec. 23, 2024 (GLOBE NEWSWIRE) — APA Corporation (“APA”) (Nasdaq: APA) announced today the extended early results as of 5:00 p.m., New York City time, on December 20, 2024 (the “Extended Early Consent Date”) of the previously announced (i) offers to exchange (the “Exchange Offers”) any and all validly tendered and accepted notes and debentures listed in the table below issued by Apache Corporation, its wholly-owned subsidiary (“Apache”), for new notes to be issued by APA (the “APA Notes”), (ii) offers to purchase for cash (the “Tender Offers” and together with the Exchange Offers, the “Offers”) up to $1,000,000,000 aggregate principal amount of any and all validly tendered and accepted Apache Notes of certain series (the “Apache Tender Notes”), and (iii) solicitations of consents (the “Consent Solicitations”) to certain...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.